Special Features

Aventus Medical Care, Inc.: Achieving Healthcare Excellence Through Innovation

C:\Users\GCPI-ROBBY\Desktop\PRS\PR 4\2.jpg

By adopting the latest technology, Aventus Medical Care, Inc. continues to focus on its mission of providing the best healthcare service to every Filipino for the past 15 years.

“Aventus has affiliated with specialized physicians trained in highly respectable institutions and integrates state-of-the-art diagnostic machines from highly regarded manufacturers in the medical field,” said Dr. Matthew Cuan, Associate Director for Multi-specialty Clinics. “Aside from focusing on medical treatment, Aventus promotes medical awareness through health education and early detection of certain diseases.”

Aventus is set to be at par with several leading healthcare providers in this country in terms of healthcare excellence. Dr. Cuan said, adding that the company has been at the forefront when it comes to consolidating the latest healthcare technology.

By partnering with Qure.ai and Astra Zeneca in the screening for early risk detection of lung nodules, the company strengthens the thrust that it has been known for the past 15 years, he said.

The partnership with Qure.ai further expanded the company’s aim to improve services by incorporating the latest technology to provide better patient outcomes via quick and reliable diagnostic results.

C:\Users\GCPI-ROBBY\Desktop\PRS\PR 4\1.png

Dr. Matthew Cuan, Associate Director for Multi-specialty Clinics

“The incorporation of the three components mentioned will be a big leap for Aventus towards its commitment to healthcare excellence,” Dr. Cuan explained.

Aventus Medical Care, Inc. has always been at the forefront when it comes to acquiring the latest healthcare technology.

“The use of AI in the fight against lung cancer via early detection of lung nodes in several countries has shown the vast leap in technology and the impact it has on the outcome of patients who benefitted from it,” he pointed out. “Aventus embraced this remarkable opportunity to be part of a milestone in which patients under our care will also benefit from the desired outcome.”

C:\Users\GCPI-ROBBY\Desktop\PRS\PR 4\3.jpeg

In partnering with Qure.ai and Astra Zeneca, the company enhances its capability in the early detection of lung nodules. Lung nodules are small growths that may either be benign or could be early-stage cancer.

The Global Cancer Observatory reported that in 2020, there were over 17,000 deaths related to lung cancer in the Philippines. This accounts for 18.4 percent of total cancer-related deaths in the country.